Global Extracorporeal Membrane Oxygenation Machine Market Research Report (2021 to 2026) – by Modality, Age and Region

This post was originally published on this site

DUBLIN, Sept. 14, 2021 /PRNewswire/ — The “Extracorporeal Membrane Oxygenation Machine Market Research Report by Modality, by Age, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19” report has been added to’s offering.

The Global Extracorporeal Membrane Oxygenation Machine Market size was estimated at USD 292.52 Million in 2020 and expected to reach USD 317.67 Million in 2021, at a Compound Annual Growth Rate (CAGR) 8.93% to reach USD 488.82 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies – USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Extracorporeal Membrane Oxygenation Machine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Extracorporeal Membrane Oxygenation Machine Market, including Abbott Laboratories, Alung Technologies, Inc., Eurosets S.R.L., Getinge AB, Livanova PLC, Medtronic PLC, Microport Scientific Corporation, Nipro Corporation, Origen Biomedical, Inc., Terumo Corporation, and Xenios AG.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Extracorporeal Membrane Oxygenation Machine Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Extracorporeal Membrane Oxygenation Machine Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Extracorporeal Membrane Oxygenation Machine Market?

4. What is the competitive strategic window for opportunities in the Global Extracorporeal Membrane Oxygenation Machine Market?

5. What are the technology trends and regulatory frameworks in the Global Extracorporeal Membrane Oxygenation Machine Market?

6. What is the market share of the leading vendors in the Global Extracorporeal Membrane Oxygenation Machine Market?

7. What modes and strategic moves are considered suitable for entering the Global Extracorporeal Membrane Oxygenation Machine Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Cumulative Impact of COVID-19

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers Increasing prevalence of cardiovascular and respiratory diseases Increased adoption of ECMO systems owing to technology advancement

5.1.2. Restraints Dearth of skilled professionals

5.1.3. Opportunities Adoption of ECMO in the settings of lung transplantation and technical advancements Rising awareness about the benefits of ECMO machines

5.1.4. Challenges High cost associated with the ECMO procedures

5.2. Porters Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Threat of Substitutes

5.2.3. Bargaining Power of Customers

5.2.4. Bargaining Power of Suppliers

5.2.5. Industry Rivalry

6. Extracorporeal Membrane Oxygenation Machine Market, by Modality

6.1. Introduction

6.2. Arteriovenous ECMO

6.3. Venoarterial ECMO

6.4. Venovenous ECMO

7. Extracorporeal Membrane Oxygenation Machine Market, by Application

7.1. Introduction

7.2. Cardiac Application

7.3. Extracorporeal Cardiopulmonary Resuscitation

7.4. Respiratory Application

8. Extracorporeal Membrane Oxygenation Machine Market, by Age

8.1. Introduction

8.2. Adult

8.3. Neonate

8.4. Pediatric

9. Americas Extracorporeal Membrane Oxygenation Machine Market

9.1. Introduction

9.2. Argentina

9.3. Brazil

9.4. Canada

9.5. Mexico

9.6. United States

10. Asia-Pacific Extracorporeal Membrane Oxygenation Machine Market

10.1. Introduction

10.2. Australia

10.3. China

10.4. India

10.5. Indonesia

10.6. Japan

10.7. Malaysia

10.8. Philippines

10.9. Singapore

10.10. South Korea

10.11. Thailand

11. Europe, Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market

11.1. Introduction

11.2. France

11.3. Germany

11.4. Italy

11.5. Netherlands

11.6. Qatar

11.7. Russia

11.8. Saudi Arabia

11.9. South Africa

11.10. Spain

11.11. United Arab Emirates

11.12. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix

12.1.1. Quadrants

12.1.2. Business Strategy

12.1.3. Product Satisfaction

12.2. Market Ranking Analysis

12.3. Market Share Analysis, By Key Player

12.4. Competitive Scenario

12.4.1. Merger & Acquisition

12.4.2. Agreement, Collaboration, & Partnership

12.4.3. New Product Launch & Enhancement

12.4.4. Investment & Funding

12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

13.1. Abbott Laboratories

13.2. Alung Technologies, Inc.

13.3. Eurosets S.R.L.

13.4. Getinge AB

13.5. Livanova PLC

13.6. Medtronic PLC

13.7. Microport Scientific Corporation

13.8. Nipro Corporation

13.9. Origen Biomedical, Inc.

13.10. Terumo Corporation

13.11. Xenios AG

14. Appendix

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904

Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links